Alinari L - Search Results

1

Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma.

Alinari L, White VL, Earl CT, Ryan TP, Johnston JS, Dalton JT, Ferketich AK, Lai R, Lucas DM, Porcu P, Blum KA, Byrd JC, Baiocchi RA. Alinari L, et al. MAbs. 2009 Jan-Feb;1(1):31-40. doi: 10.4161/mabs.1.1.7472. MAbs. 2009. PMID: 20046572 Free PMC article.

2

Rituximab in primary conjunctiva lymphoma.

Zinzani PL, Alinari L, Stefoni V, Loffredo A, Pichierri P, Polito E. Zinzani PL, et al. Among authors: alinari l. Leuk Res. 2005 Jan;29(1):107-8. doi: 10.1016/j.leukres.2004.05.011. Leuk Res. 2005. PMID: 15541482

3

Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia.

Alinari L, Lapalombella R, Andritsos L, Baiocchi RA, Lin TS, Byrd JC. Alinari L, et al. Oncogene. 2007 May 28;26(25):3644-53. doi: 10.1038/sj.onc.1210380. Oncogene. 2007. PMID: 17530018 Review.

4

Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma.

Zinzani PL, Musuraca G, Tani M, Stefoni V, Marchi E, Fina M, Pellegrini C, Alinari L, Derenzini E, de Vivo A, Sabattini E, Pileri S, Baccarani M. Zinzani PL, et al. Among authors: alinari l. J Clin Oncol. 2007 Sep 20;25(27):4293-7. doi: 10.1200/JCO.2007.11.4207. Epub 2007 Aug 20. J Clin Oncol. 2007. PMID: 17709797 Clinical Trial.

5

VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly.

Fina M, Tani M, Stefoni V, Musuraca G, Marchi E, Pellegrini C, Alinari L, Derenzini E, Bacci F, Pileri S, Baccarani M, Zinzani PL. Fina M, et al. Among authors: alinari l. Leuk Lymphoma. 2007 Nov;48(11):2167-71. doi: 10.1080/10428190701642102. Leuk Lymphoma. 2007. PMID: 17990178 Clinical Trial.

6

Subcutaneous alemtuzumab for Sézary Syndrome in the very elderly.

Alinari L, Geskin L, Grady T, Baiocchi RA, Bechtel MA, Porcu P. Alinari L, et al. Leuk Res. 2008 Aug;32(8):1299-303. doi: 10.1016/j.leukres.2007.11.009. Epub 2007 Dec 21. Leuk Res. 2008. PMID: 18096224

7

Methylation of histone H3 and H4 by PRMT5 regulates ribosomal RNA gene transcription.

Majumder S, Alinari L, Roy S, Miller T, Datta J, Sif S, Baiocchi R, Jacob ST. Majumder S, et al. Among authors: alinari l. J Cell Biochem. 2010 Feb 15;109(3):553-63. doi: 10.1002/jcb.22432. J Cell Biochem. 2010. PMID: 19998411 Free PMC article.

8

New targets of therapy in T-cell lymphomas.

Erter J, Alinari L, Darabi K, Gurcan M, Garzon R, Marcucci G, Bechtel MA, Wong H, Porcu P. Erter J, et al. Among authors: alinari l. Curr Drug Targets. 2010 Apr;11(4):482-93. doi: 10.2174/138945010790980376. Curr Drug Targets. 2010. PMID: 20196721 Free PMC article. Review.

9

FTY720 shows promising in vitro and in vivo preclinical activity by downmodulating Cyclin D1 and phospho-Akt in mantle cell lymphoma.

Liu Q, Alinari L, Chen CS, Yan F, Dalton JT, Lapalombella R, Zhang X, Mani R, Lin T, Byrd JC, Baiocchi RA, Muthusamy N. Liu Q, et al. Among authors: alinari l. Clin Cancer Res. 2010 Jun 15;16(12):3182-92. doi: 10.1158/1078-0432.CCR-09-2484. Epub 2010 May 11. Clin Cancer Res. 2010. PMID: 20460491 Free PMC article.

10

The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo.

Lucas DM, Alinari L, West DA, Davis ME, Edwards RB, Johnson AJ, Blum KA, Hofmeister CC, Freitas MA, Parthun MR, Wang D, Lehman A, Zhang X, Jarjoura D, Kulp SK, Croce CM, Grever MR, Chen CS, Baiocchi RA, Byrd JC. Lucas DM, et al. Among authors: alinari l. PLoS One. 2010 Jun 3;5(6):e10941. doi: 10.1371/journal.pone.0010941. PLoS One. 2010. PMID: 20532179 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page